启明创投医疗创新投资团队招聘27届实习

Swipe Left for the English Version

5月11日，启明创投医疗创新投资团队2026PhD暑期实习生计划启动，如果你对投资和创业充满热情，请即刻投递简历！

关于启明创投

启明创投是具有全球良好声誉的顶尖创投机构，目前旗下管理11只美元基金，7只人民币基金，已募管理资产总额达到95亿美元。自成立至今，专注于投资科技（Technology）、医疗创新（Healthcare）等行业早期和成长期的优秀企业。

启明创投拥有一支由创始人、企业家、科学家、工程师、医生、咨询顾问、财务专家等组成的专业投资人团队，对建立并运营一家企业拥有丰富的经验。启明创投创办20年以来，已投资的高速成长的医疗创新企业，其中绝大多数已经成长为各自领域的领军者，并在启明创投生态圈内协同发展，在更多创新领域创造更大的价值。

包容、进取、谦逊和真诚是我们的企业文化，在这里同事相处融洽，工作氛围和谐友善，团队合作紧密。我们希望和新生代力量一起寻找最优秀的创业者，解决临床需求，为社会创造福祉。

加入启明创投PhD暑期实习生计划

你将有独特的机会收获

• 对创投领域的全面了解与扎实训练：依托扎实的市场研究，你将与医疗创新领域的行业专家密切合作，参与项目挖掘、尽职调查、交易执行等完整的创投日常，全面培养你在医疗创新领域早期投资的基本技能与行业洞见；

• 沉浸式实践历练：与我们的专业合伙人以及行业顶级导师一起合作，深入参与到投资实践当中。并将有机会直接与初创公司创始人交流，识别市场机会、评估交易价值；

  
  

• 建立医疗行业广泛的人脉：直接与启明创投投资组合公司有影响力的创始人及行业领袖面对面交流与深入合作，在帮助企业的同时，也积累专业知识，构建属于自己的医疗行业人脉网络；

• 创造真正的影响：你的研究成果将正式呈现给我们的投资团队，并获得专业反馈和针对性指导，甚至可能直接影响我们的投资决策；

• 优异表现可获得持续发展机会：实习期间表现优秀者，暑期实习结束后可继续获得远程兼职实习机会；综合表现特别优秀者，更有机会获得正式全职岗位。

我们期待你

• 来自全球顶尖高校的PhD在读学生

• 当前PhD研究方向包括但不限于：生物医学、生物工程、AI医疗、医疗具身智能等

• 对前沿科技具备敏锐洞察力与判断力，以及极强的探索欲

• 有强烈的创业者精神

暑期实习将全职工作于北京或上海，实习期间需可接受国内灵活出差安排

即刻投递

共同经历行业发展！

请在简历中注明姓名、学校、专业及当前PhD年级

PhD Summer Associate Healthcare Shanghai / Beijing

Biotech / Medtech / AI Healthcare

On May 11, the Healthcare Investment Team of Qiming Venture Partners launches our 2026 Healthcare PhD Summer Internship Program. Start Your Healthcare Investment Journey with us now! 

Through this 8-10 weeks internship program, you will gain hands-on experience to work with the most innovative founders across Biotech, Medtech, AI in Healthcare and more, and get growth opportunities.

About Qiming Venture Partners

Qiming Venture Partners was founded in 2006. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Healthcare industries at the early and growth stages.

Our professional investment team consists of founders, entrepreneurs, scientists, engineers, doctors, consultants, and financial experts. We have extensive experiences in building and operating a business.

Since our establishment, Qiming Venture Partners has earned extensive recognition from investors worldwide and has become an ideal VC firm for entrepreneurs, due to our exceptional investment performance. Qiming Venture Partners and our partners consistently rank among the leaders in the global venture capital industry across various prestigious lists.

Inclusion, staying hungry, humility, and sincerity are the core values of Qiming Venture Partners. We enjoy a friendly, harmonious, and cooperative working environment. We hope to work with young talents to find outstanding entrepreneurs, address clinical needs, and create social welfare.

Get a unique chance:

• A comprehensive exposure to the magic VC world: Through solid market research, you will work closely with our healthcare experts on deal sourcing, due diligence, and deal execution to shape your early-stage investment themes in healthcare.

• Learn from practice: Train with our expert partners and top industry mentors in the fundamentals of VC investment. You will talk directly to start-up founders, to identify market opportunities and assess real-world deal dynamics.

• Broad network in the healthcare industry: Directly communicate with influential CEOs of Qiming Venture Partners portfolio companies and industry KOLs. Help them, and in turn, help yourself to build your own industry network!

• Make a real impact: Formally present your findings to our VC investment team for feedback and mentorship. Your input may directly influence our investment decisions. 

• Ongoing opportunities: Qualified interns will be offered a remote part-time internship after the summer internship. Outstanding candidates will have an opportunity for a full-time position after the program.

  
  

Qualifications:

• PhD candidate from a top-tier school in the US/UK.

• Current PhD fields include, but are not limited to: biomedical, bioengineering, AI in healthcare, robotics related to healthcare, etc.

• Sharp instinct for cutting-edge technologies.

• Strong entrepreneurial spirit.

• On-site in Beijing/Shanghai during the summer, and flexible to travel.

往 期 回 顾

启明创投成立于2006年。目前，启明创投旗下管理11只美元基金，7只人民币基金，已募管理资产总额达到95亿美元。自成立至今，专注于投资科技(Technology)、医疗创新(Healthcare)等行业早期和成长期的优秀企业。

截至目前，启明创投已投资超过580家高速成长的创新企业，其中有超过210家分别在美国纽交所、纳斯达克，香港交易所，上交所及深交所等交易所上市，或通过并购等方式退出，有80多家企业成为行业公认的独角兽或超级独角兽企业。

启明创投投资企业中，很多已经成长为各自领域中最具影响力的公司，包括小米集团（01810.HK）、美团（03690.HK）、哔哩哔哩（NASDAQ:BILI, 09626.HK）、知乎（NYSE:ZH, 02390.HK）、石头科技（688169.SH）、禾赛科技（NASDAQ:HSAI,02525.HK）、优必选（09880.HK）、文远知行（NASDAQ:WRD, 0800.HK）、海博思创（688411.SH）、影石创新（688775.SH）、云知声（09678.HK）、壁仞科技（06082.HK）、智谱（02513.HK）、甘李药业（603087.SH）、泰格医药（300347.SZ, 03347.HK）、再鼎医药（NASDAQ:ZLAB, 09688.HK）、康希诺生物（688185.SH, 06185.HK）、Schrödinger（NASDAQ:SDGR）、惠泰医疗（688617.SH）、三友医疗（688085.SH）、艾德生物（300685.SZ）、神州细胞（688520.SH）、英矽智能（03696.HK）、浩博生物、圆心科技、宜联生物、礼新医药、阶跃星辰等。